0001140361-22-009654.txt : 20220315 0001140361-22-009654.hdr.sgml : 20220315 20220315213025 ACCESSION NUMBER: 0001140361-22-009654 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220311 FILED AS OF DATE: 20220315 DATE AS OF CHANGE: 20220315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Esfandiari Javan CENTRAL INDEX KEY: 0001397402 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35569 FILM NUMBER: 22743137 MAIL ADDRESS: STREET 1: 3661 HORSEBLOCK ROAD CITY: MEDFORD STATE: NY ZIP: 11763 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC. CENTRAL INDEX KEY: 0001092662 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880425691 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 555 WIRELESS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 BUSINESS PHONE: (631) 924-1135 MAIL ADDRESS: STREET 1: 555 WIRELESS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 FORMER COMPANY: FORMER CONFORMED NAME: Chembio Diagnostics Inc. DATE OF NAME CHANGE: 20040607 FORMER COMPANY: FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC DATE OF NAME CHANGE: 19990805 4 1 form4.xml FORM 4 X0306 4 2022-03-11 0001092662 CHEMBIO DIAGNOSTICS, INC. CEMI 0001397402 Esfandiari Javan C/O CHEMBIO DIAGNOSTICS, INC. 555 WIRELESS BOULEVARD HAUPPAUGE NY 11788 true See Remarks Restricted Stock Units 2021-03-11 4 A 0 144000 0 A Common Stock 144000 144000 D Incentive Stock Options 1.25 2021-03-11 4 A 0 69435 0 A 2032-03-10 Common Stock 69435 69435 D Nonqualified Stock Options 1.25 2021-03-11 4 A 0 208279 0 A 2032-03-10 Common Stock 208281 208281 D Each restricted stock unit represents a contingent right to receive one share of common stock. On March 16, 2020, the reporting person was granted 144,000 restricted stock units scheduled to vest in equal installments on March 11 of each of 2023, 2024 and 2025, subject to continued service through each vesting date. The incentive stock options are scheduled to vest and become exercisable over four years, with two shares vesting on March 11, 2023, two shares vesting on March 11, 2024, two shares vesting on March 11, 2025 and the remaining 69,429 shares vesting on March 11, 2026, subject to continued service through each vesting date. The nonqualified stock options are scheduled to vest and become exercisable over three years, with 69,426 shares vesting on March 11, 2023, 69,427 shares vesting on March 11, 2024, and 69,426 shares vesting on March 11, 2025, subject to continued service through each vesting date. Executive Vice President, Chief Science and Technology Officer /s/ Mark L. Johnson, Attorney-in-Fact for Javan Esfandiari 2022-03-15